Rezultati - Michael A. Pulsipher
- Showing 1 - 20 results of 123
- Go to Next Page
-
1
Hypogammaglobulinemia due to CAR T‐cell therapy od Andrew Doan, Michael A. Pulsipher
Izdano 2017Carta -
2
-
3
-
4
Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring and Novel Chemotherape... od Michael A. Pulsipher, Peter Bader, Thomas Klingebiel, Laurence J.N. Cooper
Izdano 2009Revisão -
5
-
6
Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association od B. E. Shaw, Dennis L. Confer, William Ying Khee Hwang, Derwood Pamphilon, Michael A. Pulsipher
Izdano 2011Revisão -
7
NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional, and Neurocognitive O... od Susan K. Parsons, Sean Phipps, Lillian Sung, K. Scott Baker, Michael A. Pulsipher, Kirsten K. Ness
Izdano 2011Artigo -
8
NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Endocrine Challenges—Thyroid Dysfunction, Growth Impairment, Bon... od Christopher C. Dvorak, Clarisa R. Gracia, Jean E. Sanders, Edward Y. Cheng, K. Scott Baker, Michael A. Pulsipher, Anna Petryk
Izdano 2011Artigo -
9
Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States od Paul V. O’Donnell, Tanya L. Pedersen, Dennis L. Confer, J. Douglas Rizzo, Michael A. Pulsipher, David Stroncek, Susan F. Leitman, Paolo Anderlini
Izdano 2010Artigo -
10
National Cancer Institute–National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on Late Effects After P... od Michael L. Nieder, George B. McDonald, Aiko Kida, Sangeeta Hingorani, Saro H. Armenian, Kenneth R. Cooke, Michael A. Pulsipher, K. Scott Baker
Izdano 2011Artigo -
11
High-Risk Neuroblastoma Treated With Tandem Autologous Peripheral-Blood Stem Cell–Supported Transplantation: Long-Term Survival Update od Rani E. George, Shuli Li, Cheryl Medeiros-Nancarrow, Donna Neuberg, Karen Marcus, Robert C. Shamberger, Michael A. Pulsipher, Stephan A. Grupp, Lisa Diller
Izdano 2006Artigo -
12
Effect of Antithymocyte Globulin Source on Outcomes of Bone Marrow Transplantation for Severe Aplastic Anemia od Joseph H. Antin, H. Joachim Deeg, Sandra Korman, Carmem Bonfim, Ryotaro Nakamura, Mary M. Horowitz, Daniel J. Weisdorf, Mary Eapen, Michael A. Pulsipher
Izdano 2014Artigo -
13
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose od Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Susan F. Leitman, Paolo Anderlini, John P. Klein, Mary M. Horowitz, J. Philip Miller, Roberta King, Dennis L. Confer
Izdano 2009Artigo -
14
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report od Saro H. Armenian, Wassim Chemaitilly, Marcus Y. Chen, Eric J. Chow, Christine Duncan, Lee W. Jones, Michael A. Pulsipher, Alan T. Remaley, Alicia Rovó, Nina Salooja, Minoo Battiwalla
Izdano 2016Artigo -
15
Myeloid lineage switch following chimeric antigen receptor T‐cell therapy in a patient with TCF3‐ZNF384 fusion‐positive B‐lymphoblastic leukemia od Matthew J. Oberley, Paul S. Gaynon, Deepa Bhojwani, Michael A. Pulsipher, Rebecca Gardner, Matthew Hiemenz, Jianling Ji, Jennifer Han, Maurice R.G. O’Gorman, Alan S. Wayne, Gordana Raca
Izdano 2018Artigo -
16
Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hemato... od Mohamed L. Sorror, Barry E. Storer, Brenda M. Sandmaier, David G. Maloney, Thomas R. Chauncey, Amelia Langston, Richard T. Maziarz, Michael A. Pulsipher, Peter A. McSweeney, Rainer Storb
Izdano 2008Artigo -
17
Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation od Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Willis H. Navarro, John E. Levine, J. Philip Miller, Bronwen E. Shaw, Paul V. O’Donnell, Navneet S. Majhail, Dennis L. Confer
Izdano 2014Artigo -
18
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review od Denise M Oliansky, Bruce Camitta, Paul S. Gaynon, Michael L. Nieder, Susan K. Parsons, Michael A Pulsipher, Hildy Dillon, Thomas A Ratko, Donna A. Wall, Philip L. McCarthy, Theresa Hahn
Izdano 2012Revisão -
19
-
20
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC03... od Michael A. Pulsipher, Kenneth M. Boucher, Donna A. Wall, Haydar Frangoul, Michel Duval, Rakesh K. Goyal, Peter J. Shaw, Ann E. Haight, Michael Grimley, Stephan A. Grupp, Morris Kletzel, Richard Kadota
Izdano 2009Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Transplantation
Hematopoietic stem cell transplantation
Biology
Immunology
Oncology
Genetics
Stem cell
Chemotherapy
Surgery
Haematopoiesis
Leukemia
Hematopoietic cell
Gastroenterology
Cyclophosphamide
Disease
Pediatrics
Bone marrow
Lymphoblastic Leukemia
Fludarabine
Immune system
Intensive care medicine
Biochemistry
Gene
Physics
Total body irradiation
Graft-versus-host disease
Clinical trial
Acute lymphocytic leukemia